AUTL
Price
$1.61
Change
+$0.02 (+1.26%)
Updated
Dec 12 closing price
Capitalization
428.49M
86 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$19.07
Change
-$0.00 (-0.00%)
Updated
Dec 12 closing price
Capitalization
1.93B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AUTL vs NRIX

Header iconAUTL vs NRIX Comparison
Open Charts AUTL vs NRIXBanner chart's image
Autolus Therapeutics
Price$1.61
Change+$0.02 (+1.26%)
Volume$3.45M
Capitalization428.49M
Nurix Therapeutics
Price$19.07
Change-$0.00 (-0.00%)
Volume$1.89M
Capitalization1.93B
AUTL vs NRIX Comparison Chart in %
AUTL
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AUTL vs. NRIX commentary
Dec 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a StrongBuy and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 15, 2025
Stock price -- (AUTL: $1.59 vs. NRIX: $19.07)
Brand notoriety: AUTL and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 79% vs. NRIX: 78%
Market capitalization -- AUTL: $428.49M vs. NRIX: $1.93B
AUTL [@Biotechnology] is valued at $428.49M. NRIX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than AUTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 5 bullish TA indicator(s).

  • AUTL’s TA Score: 5 bullish, 4 bearish.
  • NRIX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, AUTL is a better buy in the short-term than NRIX.

Price Growth

AUTL (@Biotechnology) experienced а +1.27% price change this week, while NRIX (@Biotechnology) price change was +5.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Reported Earning Dates

AUTL is expected to report earnings on Mar 10, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.93B) has a higher market cap than AUTL($428M). NRIX YTD gains are higher at: 1.221 vs. AUTL (-32.340). AUTL has higher annual earnings (EBITDA): -228.64M vs. NRIX (-248.7M). NRIX has more cash in the bank: 429M vs. AUTL (367M). NRIX has less debt than AUTL: NRIX (56.5M) vs AUTL (65.8M). NRIX has higher revenues than AUTL: NRIX (83.7M) vs AUTL (51.1M).
AUTLNRIXAUTL / NRIX
Capitalization428M1.93B22%
EBITDA-228.64M-248.7M92%
Gain YTD-32.3401.221-2,649%
P/E RatioN/AN/A-
Revenue51.1M83.7M61%
Total Cash367M429M86%
Total Debt65.8M56.5M116%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLNRIX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 27 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIVIX17.810.15
+0.85%
State Street Instl Small-Cap Equity Inv
ESPTX12.880.05
+0.39%
UBS International Sustainable Equity P2
MSVDX6.84N/A
N/A
Morgan Stanley Vitality Portfolio I
GSPTX39.04N/A
N/A
Goldman Sachs Large Cap Equity Inv
OLVCX20.49-1.23
-5.66%
JPMorgan Large Cap Value C

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with CRSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
+3.92%
CRSP - AUTL
47%
Loosely correlated
+0.87%
IMTX - AUTL
44%
Loosely correlated
-0.20%
BCYC - AUTL
42%
Loosely correlated
-1.20%
RXRX - AUTL
42%
Loosely correlated
-3.98%
NRIX - AUTL
42%
Loosely correlated
-2.75%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
-2.75%
KYMR - NRIX
65%
Loosely correlated
-2.31%
KURA - NRIX
55%
Loosely correlated
-2.61%
XNCR - NRIX
55%
Loosely correlated
-0.58%
OCUL - NRIX
54%
Loosely correlated
-4.80%
SYRE - NRIX
54%
Loosely correlated
-0.87%
More